All Articles

Albertsons and CeeDee Lamb's campaign is more than charity; it's a masterclass in leveraging corporate assets for community impact and brand value.

An upcoming summit for LGMD isn't just another conference. It's a key signal that patient advocacy, biotech innovation, and regulatory shifts are converging.

Ulster University's hosting of the Jaipur Literature Festival was more than a cultural event. It was a calculated investment in city branding and student belonging.

As healthcare costs soar, a new model is gaining traction. By earning top marks for transparency, organizations like Liberty HealthShare are building trust.

NTS Innovations brings on Dr. Art Morrish, a DARPA and Raytheon vet, to help turn its nanoscale graphene energy harvesting tech from a lab marvel into a market reality.

Thermo Fisher's latest innovations tackle medicine's toughest challenges, from cancer to preeclampsia, using automation and rapid data to redefine diagnostics.

ChainUp's spot on CNBC's top fintech list isn't just an award. It marks a pivotal moment for digital assets as institutional-grade tech replaces speculation.

A $13.6M contract for pod structures is a vital step in upgrading the Navy's EA-18G Growler with next-generation electronic warfare technology.

Beyond impressive Q2 numbers, Bank of Marin’s comeback reveals a masterclass in strategic de-risking and disciplined execution that offers lessons for the sector.

Immersion's revenue soars post-BNED deal, but profits plummet. Can a haptics innovator thrive while managing an education giant and keep investors happy?

A 30% profit drop at Ohio Valley Banc Corp. highlights a risky strategy: funding rapid loan growth with costly deposits as major credit issues emerge.

FDA clears a pivotal study for Medicus Pharma's SkinJect, a microneedle patch offering new hope for Gorlin Syndrome and a new playbook in biotech strategy.

A Crown corporation's new flyer service is gutting community newspapers, sparking a crisis that pits public service against profit and threatens local democracy.

Rosenberg & Parker's new Financial Institutions Practice, led by Nathan Hummel, signals a major shift in how banks manage risk and capital.

Small biotech Veru Inc. is betting its future on improving blockbuster weight-loss drugs, targeting the hidden cost of muscle loss in a billion-dollar market.

A novel partnership aims to create the first drug for ReNU syndrome, a condition found in 2024, potentially redefining rare disease drug development.

DBGI announced a massive program expansion, but a recent stock split, weak financials, and a fight against market anomalies paint a complex picture.

Catalogic's latest DPX release adds agentless Proxmox protection and deepens cyber resilience, a strategic move to unify data management in a fragmenting IT world.

Geospatial leader ProStar appoints Michael Wolff to transition from founder-led innovation to global market dominance in critical infrastructure mapping.